1. Shields AF, Grierson JR, Dohmen BM, et al. (1998) Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med 4:1334–1336
2. Lu L, Samuelsson L, Bergstrom M, et al. (2002) Rat studies comparing 11C-FMAU, 18F-FLT, and 76Br-BFU as proliferation markers. J Nucl Med 43:1688–1698
3. Dittman H, Dohmen BM, Kehibach R, et al. (2002) Early changes in [18F]FLT uptake after chemotherapy: an experimental study. Eur J Nucl Med 29:1462–1469
4. Veselle H, Grierson J, Muzi M, et al. (2002) In vivo validation of 3′deoxy-3′-[18F]fluorothymidine ([18F]FLT) as a proliferation imaging tracer in humans: correlation of [18F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors. Clin Cancer Res 8:3315–3323
5. Wagner M, Seitz U, Buck A, et al. (2003) 3′-[18F]fluoro-3′-deoxythymidine ([18F]-FLT) as positron emission tomography tracer for imaging proliferation is a murine B-cell lymphoma model and in the human disease. Cancer Res 63:2681–2687